Dear Colleagues and Friends,
It is indeed a great pleasure to participate in the opening ceremony of EuroPCR 2011, the annual meeting organised by EAPCI and PCR.
I am glad to hear that 12.000 participants have registered so far, demonstrating therefore that this meeting is the annual forum of Interventional Cardiology in Europe.
I would like to congratulate the organisers for the excellence of the scientific programme developed in PCR 2011 and the very high profile of the international faculty invited today in Paris.
The major progresses accomplished in Interventional Cardiology will be discussed by a distinguished group of experts who will provide all of us an up to date and high quality education.
EuroPCR is organised by PCR and by our Association on Interventional Cardiology EAPCI. We, the ESC, consider as a fundamental strategic objective the development of a strong dynamic and well structured Association on Interventional Cardiology, within our common house, i.e the ESC, and we want this Association to play a major role in Education, Guidelines and Registries.
The foundation act of the creation of EAPCI is the merit of Jean Marco, W. Winjs and of several other colleagues.
Time has come now for consolidation and then for expansion of the Association. After Carlo Di Mario, Jean Fajadet and his successors will therefore have the responsibility to develop the Association in partnership with PCR.
The working model of EAPCI is indeed particular within the ESC since the four other Associations are entirely managed by our society, the ESC.
We acknowledge the fact that Interventional Cardiology in Europe has grown rapidly in liaison with a private partner, Europa. This partnership has indeed been successful and we do not see any reason to discuss an alternative model as far as the principle of the development of an Association on Interventional Cardiology, under the auspices of the ESC, is the common objective accepted by all parties.
There are indeed opportunities for joint actions around the globe and particularly in fast developing areas such as Asia pacific, Southern America, Middle-East in order to promote the know-how and the scientific activities of the ESC and in particular of Interventional Cardiology.
I therefore sincerely hope that we will be able to join our forces in order to propose to our colleagues of these regions, high quality and interactive symposia, showing the best of European cardiology at large.
We, as professionals, are facing a changing world through more stringent regulations. Moreover, the economic context as well as the global perception of the medical profession by the public, and by the decision-makers will lead to changing modalities in industry support, be it devices, diagnostic or pharma.
Therefore, Interventional Cardiology is and will be concerned as well as cardiology at large, and one of the tasks of the future leadership of Interventional Cardiology in Europe, will be to get prepared to this new challenge and to rethink the current business model.
One solution, which is currently under discussion within the ESC Central, could be to move from a client system to a membership system, where members of the PCI family would get a wide array of exclusive services as we will probably do for the ESC Central in the future.
To conclude, I would like to convey the warmest regards of the ESC to you and to thank EuroPCR for this very kind invitation.
I wish you a very fruitful meeting and I hope that the coming year will provide opportunities to further strengthen the friendly links which already exist between EAPCI, PCR and the European society of Cardiology.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved